The Enterprise Value as of December 2025 (TTM) for Simcere Pharmaceutical Group Limited (2096.HK) is 27.73B

According to Simcere Pharmaceutical Group Limited’s latest financial reports and current stock price. The company's current Enterprise Value is 27.73B. This represents a change of 67.01% compared to the average of 16.60B of the last 4 quarters.

Simcere Pharmaceutical Group Limited (2096.HK) Historical Enterprise Value (quarterly & annually)

How has 2096.HK Enterprise Value performed in the past?

The mean historical Enterprise Value of Simcere Pharmaceutical Group Limited over the last ten years is 19.67B. The current 27.73B Enterprise Value has changed 13.99% with respect to the historical average. Over the past ten years (40 quarters), 2096.HK's Enterprise Value was at its highest in in the June 2021 quarter at 31.70B. The Enterprise Value was at its lowest in in the December 2013 quarter at 35.13M.

Simcere Pharmaceutical Group Limited (2096.HK) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Simcere Pharmaceutical Group Limited Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Simcere Pharmaceutical Group Limited (2096.HK) Average Enterprise Value

How has 2096.HK Enterprise Value performed in the past?

The current Enterprise Value of Simcere Pharmaceutical Group Limited (2096.HK) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Simcere Pharmaceutical Group Limited (2096.HK) Enterprise Value vs. Peers

How is 2096.HK’s Enterprise Value compared to its peers?

Simcere Pharmaceutical Group Limited’s Enterprise Value is greater than Asymchem Laboratories (Tianjin) Co., Ltd. (25.23B), less than Shanghai Henlius Biotech, Inc. (33.54B), greater than Duality Biotherapeutics, Inc. (23.89B), greater than Genscript Biotech Corporation (3.95B), greater than China Medical System Holdings Limited (26.37B), less than China Resources Pharmaceutical Group Limited (100.31B), greater than Livzon Pharmaceutical Group Inc. (25.78B), less than Grand Pharmaceutical Group Limited (32.82B), greater than Ascentage Pharma Group International (19.01B), less than Shanghai Junshi Biosciences Co., Ltd. (35.89B),

Build a custom stock screener for Simcere Pharmaceutical Group Limited (2096.HK) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Simcere Pharmaceutical Group Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Simcere Pharmaceutical Group Limited (2096.HK) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Simcere Pharmaceutical Group Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.